A common painkiller may be quietly changing cancer risk
Billy Candra Ibuprofen, a ubiquitous non-steroidal anti-inflammatory drug (NSAID) found in medicine cabinets worldwide, is primarily known...
women’s health
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth.
A groundbreaking experimental immunotherapy, developed by scientists at the Icahn School of Medicine at Mount...
Japanese Tree Frog Intestinal Bacterium Shows Unprecedented Success in Eliminating Colorectal Cancer Tumors in Mice
George Ongkojoyo A research team at the Japan Advanced Institute of Science and Technology (JAIST) has announced...
Research has shed light on how a new type of antibody treatment reactivates patients’ immune cells to fight ovarian cancer.
A groundbreaking study led by Professor Sophia Karagiannis at King’s College London has unveiled the...
Radiation Therapy Transforms Immunotherapy Resistant Lung Cancer into Treatable Tumors According to Johns Hopkins Research
By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy...
Long-Term Estrogen-Based Hormone Therapy May Positively Influence Cardiovascular Health During Menopause, Penn State-Led Study Reveals
The decision to initiate hormone therapy (HT) during the menopause transition, a pivotal life phase...
Breakthrough lung cancer treatment supercharges immune cells with mitochondria
The global oncology community has long grappled with the dual-edged sword of chemotherapy, a treatment...
Researchers resolve uncertainty in BRCA2 testing, improving cancer risk assessment and patient care
Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer...
Common Over-the-Counter Painkillers Ibuprofen and Acetaminophen Found to Accelerate Global Antibiotic Resistance Crisis
New research from the University of South Australia has identified a significant and previously underestimated...
Novel Combination Drug Shows Promise as Tamoxifen Alternative for Breast Cancer Prevention, Mitigating Metabolic Risks in Obese Women
Approximately 25% of women in the United States between ages 45 and 60, a critical...
